Holen Sie sich die Stockscreener-App
8.77
5.29%
-0.49
Finanzdaten der Ventyx Biosciences Inc-Aktie (VTYX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
2.54%
29.33
|
30.10 | 32.42 | 38.55 | 35.71 |
| Operating Income/Loss |
2.54%
-29.33
|
-30.10 | -32.42 | -38.55 | -35.71 |
| Nonoperating Income/Loss |
11.70%
2.346
|
2.657 | 3.067 | 3.303 | 3.762 |
| Income/Loss From Continuing Operations Before Tax |
1.65%
-26.99
|
-27.44 | -29.32 | -35.25 | -31.95 |
| Income/Loss From Continuing Operations After Tax |
1.65%
-26.99
|
-27.44 | -29.32 | -35.25 | -31.95 |
|
Net Income/Loss
|
1.65%
-26.99
|
-27.44 | -29.35 | -35.25 | -31.95 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.09%
71.20
|
71.13 | 0.7832 | 70.67 | 70.55 |
| Diluted Average Shares |
0.09%
71.20
|
71.13 | 0.7832 | 70.67 | 70.55 |
| Basic Earnings Per Share |
2.56%
-0.38
|
-0.39 | -0.41 | -0.50 | -0.45 |
| Diluted Earnings Per Share |
2.56%
-0.38
|
-0.39 | -0.41 | -0.50 | -0.45 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
5.44%
0.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):